Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
HER2异质性对早期HER2阳性乳腺癌治疗反应的影响：T-DM1联合帕妥珠单抗的II期新辅助临床试验
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-20-1557
Filho, Otto Metzger; Viale, Giuseppe; Stein, Shayna; Trippa, Lorenzo; Yardley, Denise A; Mayer, Ingrid A; Abramson, Vandana G; Arteaga, Carlos L; Spring, Laura M; Waks, Adrienne G; Wrabel, Eileen; DeMeo, Michelle K; Bardia, Aditya; Dell'Orto, Patrizia; Russo, Leila; King, Tari A; Polyak, Kornelia; Michor, Franziska; Winer, Eric P; Krop, Ian E
